skip to Main Content

Antidepressant Use and the Risk of Primary Open Angle Glaucoma

​The goal of this project is to address the following research question: Does the use of antidepressant treatment, specifically, selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs), reduce the risk of primary open angle glaucoma?

Investigator: Jorgenson, Eric

Funder: Northern California Community Benefit Programs

Explore all studies and publications

Back To Top